UBE2C

Across TCGA pan-cancer cohorts, UBE2C RNA differs between tumor and matched normal tissue in 18 of 18 cancer types tested, making tumor–normal expression one of UBE2C’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where UBE2C RNA is more highly expressed in tumor relative to normal tissue. In most cancer types UBE2C is over-expressed in tumor.

HNSC, BLCA, and LUAD are the cancer types where UBE2C tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2C RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	III,IV	+2.692	<.001	12	view →
BLCA	Male	IV	+5.447	<.001	11	view →
LUAD	Male	III,IV	+4.535	<.001	11	view →
KIRP	Male	III,IV	+3.410	<.001	11	view →
KIRC	Male	IV	+2.660	<.001	11	view →
COAD	Female	II,III,IV	+2.316	<.001	11	view →
KICH	All	II,III,IV	+2.223	<.001	10	view →
THCA	All	III,IV	+1.548	<.001	10	view →
LUSC	Female	II,III,IV	+5.185	<.001	9	view →
STAD	Female	All	+4.708	<.001	9	view →
LIHC	Female	II,III,IV	+3.510	<.001	9	view →
UCEC	All	II,III,IV	+5.328	<.001	8	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 18 lineages.

UBE2C–HNSC

Open the HNSC breakdown →